Remco de Bree Selected Research

Enteral Nutrition (Feeding, Tube)

2/2022	Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation.
1/2022	Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
1/2020	Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
4/2017	Indicators for Enteral Nutrition Use and Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Remco de Bree Research Topics

Disease

64	Neoplasms (Cancer) 12/2023 - 10/2003
55	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 09/2003
55	Squamous Cell Carcinoma of Head and Neck 07/2023 - 11/2002
24	Carcinoma (Carcinomatosis) 04/2024 - 09/2003
23	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2002
12	Margins of Excision 08/2023 - 11/2007
9	Lymphatic Metastasis 05/2024 - 10/2004
9	Mouth Neoplasms (Oral Cancer) 12/2023 - 10/2012
8	Laryngeal Neoplasms (Laryngeal Cancer) 05/2024 - 06/2011
7	Hypoxia (Hypoxemia) 01/2023 - 01/2011
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2024 - 08/2004
6	Oropharyngeal Neoplasms 12/2023 - 09/2005
5	Fistula 01/2024 - 08/2014
4	Sarcopenia 04/2022 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 12/2017
3	Adenoid Cystic Carcinoma (Cylindroma) 06/2020 - 09/2017
3	Hypothyroidism 05/2009 - 03/2007
2	Fatigue 02/2024 - 11/2022
2	Mental Disorders (Mental Disorder) 11/2023 - 12/2019
2	Melanoma (Melanoma, Malignant) 06/2023 - 12/2008
2	Disease Progression 03/2023 - 12/2021
2	Granuloma 01/2023 - 05/2004
2	Trismus (Lockjaw) 02/2022 - 01/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2009
2	Frailty 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 05/2004
2	Infections 01/2020 - 05/2003
2	Hypopharyngeal Neoplasms 01/2019 - 03/2007
2	Nasopharyngeal Carcinoma 01/2018 - 06/2016
2	Residual Neoplasm 11/2015 - 10/2003
2	Sarcoma (Soft Tissue Sarcoma) 05/2015 - 01/2006
2	Gustatory Sweating (Frey's Syndrome) 03/2009 - 08/2007
1	Paraganglioma (Paragangliomas) 02/2024
1	Weight Loss (Weight Reduction) 02/2024
1	Tongue Neoplasms (Tongue Neoplasm) 01/2024
1	Pneumonia (Pneumonitis) 02/2022
1	Deglutition Disorders (Dysphagia) 02/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Neutropenia 01/2022
1	Cachexia 01/2022
1	Body Weight (Weight, Body) 01/2022

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2016
7	AntigensIBA 11/2023 - 09/2004
7	Monoclonal AntibodiesIBA 11/2009 - 11/2002
6	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 12/2015
5	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2019 - 02/2007
4	pimonidazoleIBA 01/2023 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 02/2010
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 06/2016
3	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 05/2012
3	carbogenIBA 01/2022 - 05/2012
3	Circulating Tumor DNAIBA 12/2021 - 01/2017
3	(124)I-cMAb U36IBA 11/2009 - 11/2002
3	monoclonal antibody BIWA 4 (bivatuzumab)IBA 10/2003 - 09/2003
2	Cell-Free Nucleic AcidsIBA 12/2021 - 12/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2019 - 05/2003
2	ParaffinIBA 02/2019 - 01/2018
2	Radioisotopes (Radionuclides)IBA 01/2018 - 11/2009
2	Nucleic AcidsIBA 12/2017 - 01/2017
2	AlbuminsIBA 04/2013 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 04/2011 - 08/2002
2	Type A Botulinum Toxins (Botox)FDA Link 03/2009 - 08/2007
1	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2024
1	Edotreotide (SMT 487)IBA 02/2024
1	A 7 (A-7)IBA 01/2024
1	LigandsIBA 11/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023
1	B7-H1 AntigenIBA 03/2023
1	Inosine Diphosphate (IDP)IBA 01/2023
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023
1	Carbon DioxideIBA 04/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022

Therapy/Procedure

59	Radiotherapy 04/2024 - 08/2004
33	Therapeutics 08/2023 - 09/2003
27	Neck Dissection (Radical Neck Dissection) 05/2024 - 01/2004
21	Chemoradiotherapy 05/2024 - 08/2014
16	Aftercare (After-Treatment) 11/2023 - 09/2005
14	Drug Therapy (Chemotherapy) 04/2024 - 04/2009
13	Laryngectomy 01/2024 - 05/2005
5	Free Tissue Flaps 10/2022 - 08/2002
5	Radioimmunotherapy 09/2004 - 11/2002
4	Induction Chemotherapy 03/2023 - 12/2015
4	Palliative Care (Palliative Therapy) 07/2022 - 09/2012
4	Enteral Nutrition (Feeding, Tube) 02/2022 - 04/2017
4	General Anesthesia 01/2022 - 11/2007
4	Adjuvant Radiotherapy 02/2013 - 09/2005
3	Length of Stay 01/2022 - 01/2019
2	Operative Surgical Procedures 01/2024 - 12/2021
2	Computer-Assisted Surgery (Image Guided Surgery) 01/2023 - 01/2022
2	Gastrostomy 01/2020 - 04/2017
2	Combined Modality Therapy 01/2019 - 12/2015
2	Re-Irradiation 01/2015 - 04/2006
2	Lymph Node Excision (Lymph Node Dissection) 06/2011 - 05/2010
2	Injections 03/2009 - 05/2004
1	Time-to-Treatment 01/2024
1	Gamma Cameras (Gamma Camera) 12/2023
1	Sutures (Suture) 01/2023
1	Lasers (Laser) 04/2022
1	Immunotherapy 02/2022